Cargando…
Implications of pharmacokinetic modeling in risk assessment analysis.
Physiologic pharmacokinetic models are a useful interface between exposure models and risk assessment models by providing a means to estimate tissue concentrations of reactive chemical species at the site of action. The models utilize numerous parameters that can be characterized as anatomical, such...
Autores principales: | Lutz, R J, Dedrick, R L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1987
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1474455/ https://www.ncbi.nlm.nih.gov/pubmed/3447907 |
Ejemplares similares
-
Pharmacokinetics of vinylidene chloride.
por: Dedrick, R L
Publicado: (1979) -
Applications of physiologic pharmacokinetic modeling in carcinogenic risk assessment.
por: Krewski, D, et al.
Publicado: (1994) -
The Implications of Using a Physiologically Based Pharmacokinetic (PBPK) Model for Pesticide Risk Assessment
por: Lu, Chensheng, et al.
Publicado: (2010) -
Enhanced renal clearance and impact on vancomycin pharmacokinetic parameters in patients with hemorrhagic stroke
por: Morbitzer, Kathryn A., et al.
Publicado: (2019) -
Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment.
por: Clewell, H J, et al.
Publicado: (2000)